Keeping up with the neighbours speeds vaccine use

Researchers at the Johns Hopkins Bloomberg School of Public Health conducted an analysis of worldwide use of Haemophilus influenza Type b vaccine (Hib) to determine what factors influenced a nation's adoption of the vaccine. The study found that a nation's eligibility for support from the Global Alliance for Vaccine and Immunisation (GAVI) and whether a country's neighbours used the vaccine were major influencing factors in addition to price of the vaccine. The findings appear in the March 16 edition of PLoS Medicine...

Read the whole article on

More from